z-logo
open-access-imgOpen Access
Growth inhibition and apoptosis-inducing effect on human cancer cells by RCE-4, a spirostanol saponin derivative from natural medicines
Author(s) -
Guiping Wang,
Wenfeng Huang,
Haibo He,
Xuejiao Fu,
Junzhi Wang,
Kun Zou,
Jianfeng Chen
Publication year - 2012
Publication title -
international journal of molecular medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.048
H-Index - 90
eISSN - 1791-244X
pISSN - 1107-3756
DOI - 10.3892/ijmm.2012.1178
Subject(s) - apoptosis , flow cytometry , cytotoxicity , cytochrome c , cancer cell , hela , cell culture , microbiology and biotechnology , annexin , chemistry , growth inhibition , cell cycle , cell , mitochondrion , biology , biochemistry , cancer , in vitro , genetics
Reineckia carnea has been used to treat several diseases in folk remedies.RCE-4 has been isolated from several plants of the family Liliaceae, but its biologicalactivity has not yet been reported. In the present study, we found that RCE-4exhibited potent cytotoxicity to the tested human cancer cell lines, and the CaSkicell line was the most sensitive with an IC50 of 3.37 µM. Thus, we presented theapoptosis-inducing effect of RCE-4 on CaSki cervical cancer cells and investigatedthe relevant mechanisms. Based on observations using transmission electron microscopy,RCE-4-treated cells manifested nuclear shrinkage, condensation and fragmentation.Annexin V/PI dual staining flow cytometry assay further confirmed that RCE-4 causeda dose-dependent early apoptotic effect. Prior to these events, RCE-4 triggereda rapid decrease of the mitochondrial membrane potential and caused the releaseof cytochrome c from the mitochondria into the cytoplasm. RCE-4 increased theexpression of Bax and decreased the expression of Bcl-2, thus augmenting the Bax/Bcl-2ratio. These findings suggest that RCE-4 induces mitochondrial-mediated apoptosisin CaSki cells and has the potential to be developed as an anticancer agent.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom